eXoZymes Secures $2M NIH Grant to Fast‑Track Rare Cannabinoid Production
eXoZymes secures $2 million NIH grant to fast‑track rare cannabinoid production, advancing AI‑powered enzyme tech for future pharma breakthroughs.
2 minutes to read
EXOZYMES INC
eXoZymes Inc Stock Bounces Back: Mid‑Cap Health‑Care Growth Potential
eXoZymes Inc’s Nasdaq stock rebounds from a $7.08 low to nearly $9.88, reflecting strategic moves amid healthcare volatility—market cap $83.8M and future growth insights.
2 minutes to read
eXoZymes Inc Faces Financial Turmoil with Negative P/E Ratio Amid Sector Challenges
eXoZymes Inc is facing significant financial struggles, with a declining stock price and negative Price Earnings ratio, raising concerns about its business model and ability to turn around its fortunes.
2 minutes to read